gene therapy, stem cells, heart failure, mutations, Mount Sinai, Hajjar

Gene therapy can clip out genetic material linked to heart failure and replace it with normal genes, according to a study from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai. The study is published in the April 29 edition of Nature Communications.

New technology developed at the Martinos Center for Biomedical Imaging at Massachusetts General Hospital (MGH) may extend the benefits of magnetic resonance imaging (MRI) to many patients whose access to MRI is currently limited. A redesign of the wire at the core of the leads carrying signals between implanted medical devices and their target structures significantly reduces the generation of heat that occurs when standard wires are exposed to the radiofrequency (RF) energy used in MRI. The novel system is described in a paper published in the online Nature journal Scientific Reports.

Stage 3 MU, stage 3meaningful use, patient engagement

The Centers for Medicare and Medicaid Services (CMS) gathered public comments on its Stage 3 Meaningful Use (MU) requirements through May 30. The third and final set of MU rules are a core part of the plan to reform the American healthcare by leveraging health information technology (IT) to help reduce costs, eliminate redundancies, and convert from a fee-for-service to a fee-for-performance reimbursement system. 

Cincinnati, Ohio-based The Christ Hospital Health Network’s Heart and Vascular Center is committed to delivering the highest quality of care to its patients. They recently deployed an integrated cardiovascular information system (CVIS) in order to support this commitment to quality.

NorthStar Medical Radioisotopes LLC has completed its first production-scale test run of the molybdenum-99 (Mo-99) aliquoting system installed at the University of Missouri Research Reactor (MURR) in Columbia, Missouri. The test and subsequent shipment of the resulting Mo-99 to NorthStar’s Madison facility is another milestone in the establishment of domestic production of the vital medical radioisotope.

A new study shows that the recently developed Compact Light Source (CLS), a commercial X-ray source, enables computed tomography (CT) scans that reveal more detail than routine scans performed at hospitals today. With roots in research and development efforts at the Department of Energy’s SLAC National Accelerator Laboratory, the new technology could soon be used in preclinical studies and help researchers better understand cancer and other diseases.

The Organization for Occupational Safety in Interventional Fluoroscopy (ORSIF) announced the release of a new documentary film on the impact of chronic, low-level exposure to ionizing radiation on physicians that practice interventional medicine in fluoroscopy labs. The documentary features noted heart surgeon Edward Diethrich, M.D., founder of the Arizona Heart Foundation.

 

 

heart stent, OAP therapy, ACS, patients, PCNA, SCAI, medication, prescribed

People with acute coronary syndrome (ACS) who undergo an angioplasty procedure and receive a heart stent are prescribed an oral antiplatelet (OAP) therapy and aspirin to help prevent a heart attack, a blood clot in their heart stent (stent thrombosis), or even death.[3]
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now